Ignite Creation Date:
2025-12-25 @ 12:10 AM
Ignite Modification Date:
2026-01-16 @ 7:44 PM
Study NCT ID:
NCT06031558
Status:
RECRUITING
Last Update Posted:
2023-09-21
First Post:
2023-08-31
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase III Study of SY-5007, a RET Inhibitor, in Patients With Locally Advanced or Metastatic RET Fusion-positive NSCLC
Sponsor:
Shouyao Holdings (Beijing) Co. LTD
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
SY-5007-III-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None